4//SEC Filing
LIPOSCIENCE INC 4
Accession 0001127602-14-033301
CIK 0001168197operating
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 3:12 PM ET
Size
17.6 KB
Accession
0001127602-14-033301
Insider Transaction Report
Form 4
LIPOSCIENCE INCLPDX
McDonald E. Duffy
Vice President, HR
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2014-11-20$2.75/sh−2,546$7,002→ 0 totalExercise: $2.50Exp: 2015-05-05→ Common Stock (2,546 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2014-11-20$1.37/sh−16,262$22,279→ 0 totalExercise: $3.88Exp: 2017-02-15→ Common Stock (16,262 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2014-11-20$2.75/sh−18,915$52,016→ 0 totalExercise: $2.50Exp: 2019-02-06→ Common Stock (18,915 underlying) - Disposition to Issuer
Common Stock
2014-11-20$5.25/sh−23,765$124,766→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2014-11-20$2.75/sh−10,185$28,009→ 0 totalExercise: $2.50Exp: 2015-11-25→ Common Stock (10,185 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2014-11-20$2.79/sh−5,575$15,554→ 0 totalExercise: $2.46Exp: 2018-04-29→ Common Stock (5,575 underlying)
Footnotes (11)
- [F1]Disposed of pursuant to the Merger Agreement and represents shares of the Issuer's common stock underlying restricted stock unit awards.
- [F10]The option was fully vested upon issuance on February 6, 2009.
- [F11]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $52,114.61, which represents the difference between the merger consideration of $5.25 per share and the exercise price of the option per share.
- [F2]Approximately 40% of the shares underlying this option were vested upon issuance on May 5, 2005, with the remainder vesting in 29 equal monthly installments thereafter.
- [F3]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $7,014.74, which represents the difference between the merger consideration of $5.25 per share and the exercise price of the option per share.
- [F4]The option vested over a period of four years, with 25% of the shares underlying the option vesting on November 25, 2006, the first anniversary of the grant date, and the remainder vesting in 36 equal monthly installments thereafter.
- [F5]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $28,061.71, which represents the difference between the merger consideration of $5.25 per share and the exercise price of the option per share.
- [F6]The option was fully vested upon issuance on February 15, 2007.
- [F7]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $22,339.11, which represents the difference between the merger consideration of $5.25 per share and the exercise price of the option per share.
- [F8]The option was fully vested upon issuance on April 29, 2008.
- [F9]Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $15,589.93, which represents the difference between the merger consideration of $5.25 per share and the exercise price of the option per share.
Documents
Issuer
LIPOSCIENCE INC
CIK 0001168197
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001168197
Filing Metadata
- Form type
- 4
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 3:12 PM ET
- Size
- 17.6 KB